Additionally, scutellarin may control the level of the transcription factor AP-1 to inhibit tumor angiogenesis in oral squamous cell carcinoma(OSCC), which is accomplished by decreasing the MMP-9 and MMP-2 levels, alongside decreasing integrin αvβ6 levels regarding human tongue cancer SAS cells. This evidence concerns the gene MMP9 and tongue cancer.